| |
 |
|
Class Information
Number: 435/343.1
Name: Chemistry: molecular biology and microbiology > Animal cell, per se (e.g., cell lines, etc.); composition thereof; process of propagating, maintaining or preserving an animal cell or composition thereof; process of isolating or separating an animal cell or composition thereof; process of preparing a composition containing an animal cell; culture media therefore > Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof > Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) > Binds a hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell surface antigen, hemoglobin, thrombospondin, glycophorin, etc.) > Binds a lymphocytic or lymphocytic-like cell or component or product thereof (e.g., b cell, b-lineage bone marrow cell, null cell, natural killer cell, b-lymphoblastoid cell, b-lineage, acute lymphoblastic leukemia cell, b-lymphocytic cell surface antigen, etc.)
Description: Subject matter involving an animal cell which produces a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a lymphocytic or lymphocytic-like cell, or with a substance shed or secreted by a lymphocytic cell or lymphocytic-like cell.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618633 |
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
Nov. 17, 2009 |
| 7547438 |
CD40-binding activating antibodies |
Jun. 16, 2009 |
| 7537763 |
Anti-CD40 monoclonal antibody |
May. 26, 2009 |
| 7445780 |
Antagonistic anti-CD40 antibodies |
Nov. 4, 2008 |
| 7425447 |
Host cells expressing 7C10 and 16C10 CD80-specific antibodies |
Sep. 16, 2008 |
| 7381560 |
Expression and use of anti-CD20 antibodies |
Jun. 3, 2008 |
| 7361345 |
Anti-CD40 antibodies capable of blocking B-cell activation |
Apr. 22, 2008 |
| 7259247 |
Anti-human T-cell costimulating polypeptide monoclonal antibodies |
Aug. 21, 2007 |
| 7241448 |
T helper cell epitopes |
Jul. 10, 2007 |
| 7220411 |
Compositions comprising anti-CCR5 antibody |
May. 22, 2007 |
| 7193064 |
Anti-CD40 monoclonal antibody |
Mar. 20, 2007 |
| 7169565 |
Antibodies to HASAV70 polypeptide |
Jan. 30, 2007 |
| 7063845 |
Human anti-CD40 antibodies |
Jun. 20, 2006 |
| 7041499 |
Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth |
May. 9, 2006 |
| 7037507 |
T helper cell epitopes |
May. 2, 2006 |
| 7030225 |
Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies |
Apr. 18, 2006 |
| 7005503 |
Human monoclonal antibody against coreceptors for human immunodeficiency virus |
Feb. 28, 2006 |
| 6987171 |
Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
Jan. 17, 2006 |
| 6972126 |
Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same |
Dec. 6, 2005 |
| 6972125 |
Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith |
Dec. 6, 2005 |
| 6913747 |
Humanized immunoglobulin reactive with B7 therewith |
Jul. 5, 2005 |
| 6875580 |
Antibodies specific for plasmacytoid dendritic cells |
Apr. 5, 2005 |
| 6849258 |
LO-CD2a antibody and uses thereof for inhibiting T cell activation and proliferation |
Feb. 1, 2005 |
| 6838261 |
Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
Jan. 4, 2005 |
| 6803039 |
Human monoclonal antibody against a costimulatory signal transduction molecule AILIM |
Oct. 12, 2004 |
| 6743898 |
Monoclonal antibodies that suppress B cell growth and/or differentiation |
Jun. 1, 2004 |
| 6737059 |
Methods of inhibiting inflammatory processes and alleviating symptoms associated with multiple sclerosis |
May. 18, 2004 |
| 6713249 |
Cell matrix plaques of initial bone formation |
Mar. 30, 2004 |
| 6685947 |
T helper cell epitopes |
Feb. 3, 2004 |
| 6620915 |
Monoclonal antibodies specific for integrin .alpha.-d subunit |
Sep. 16, 2003 |
| 6605279 |
Therapeutic compositions for inhibiting the interactions of B7-1 and B7-2 with their natural ligands |
Aug. 12, 2003 |
| 6602503 |
Recombinant anti-VLA-4 antibody molecules |
Aug. 5, 2003 |
| 6541611 |
LO-CD2b antibody |
Apr. 1, 2003 |
| 6485970 |
Immunointeractive antibody |
Nov. 26, 2002 |
| 6482598 |
Antibody recognizing a small subset of human hematopoietic cells |
Nov. 19, 2002 |
| 6479247 |
Dendritic cell-specific antibodies |
Nov. 12, 2002 |
| 6410319 |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies |
Jun. 25, 2002 |
| 6403091 |
Methods for inhibiting the rejection of a transplant organ in a subject with 5C8-specific antibodies |
Jun. 11, 2002 |
| 6365343 |
Intercellular adhesion molecule powder formulation |
Apr. 2, 2002 |
| 6333163 |
Method of facilitating HIV-1 infection through human leukotriene B4 receptor |
Dec. 25, 2001 |
| 6331615 |
Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) |
Dec. 18, 2001 |
| 6312693 |
Antibodies against human CD40 |
Nov. 6, 2001 |
| 6312692 |
Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells |
Nov. 6, 2001 |
| 6294320 |
Cell matrix plaques of initial bone formation |
Sep. 25, 2001 |
| 6274347 |
Method of producing a cell surface bound lam-1 specific antibody |
Aug. 14, 2001 |
| 6268214 |
Vectors encoding a modified low affinity nerve growth factor receptor |
Jul. 31, 2001 |
| 6242176 |
Papillomavirus cellular receptor |
Jun. 5, 2001 |
| 6235525 |
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
May. 22, 2001 |
| 6232088 |
Treatment and prevention of immune rejection reactions |
May. 15, 2001 |
| 6225117 |
Antibodies against human IL-12 |
May. 1, 2001 |
|
|
|
